What does GordonMD Global Investments LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

GordonMD Global Investments LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

KYVERNA THERAPEUTICS INC

$37M4.2M25.5%

TAYSHA GENE THERAPIES INC

$22M738K15.5%

VIR BIOTECHNOLOGY INC

$14M1.5M9.5%

BAUSCH PLUS LOMB CORP

$9M573K6.3%

AMGEN INC

$7M20K5.0%

SCHOLAR ROCK HLDG CORP

$7M133K4.5%

ULTRAGENYX PHARMACEUTICAL IN

$6M289K4.2%

PYXIS ONCOLOGY INC

$6M4.1M4.2%

TEVA PHARMACEUTICAL INDS LTD

$6M1.3M3.9%

SIONNA THERAPEUTICS INC

$5M136K3.8%

Filing history loading…